Recent Updates
Recently added Catalysts
BDX Positive Sentiment

BD To Host Virtual 2026 Annual Meeting of Shareholders

Key Takeaway: BD (Becton, Dickinson and Company) will host its virtual 2026 Annual Meeting of Shareholders on January 27, 2026. Shareholders as of December 8, 2025, can participate and vote, while guests can listen in. A replay will be available for one year on the BD website. The meeting highlights BD's commitment to health care innovation.
Price reaction · baseline $202.74 (2026-01-12 close) · hit pre-market · 3 other BDX headline(s) in the window, move may be shared
day 0 close · peak
-0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is hosting a virtual meeting, enhancing accessibility for shareholders.
  • Shareholders can actively participate and ask questions during the meeting.
  • The company emphasizes its commitment to health care advancements.

Full Press Release Details

FRANKLIN LAKES, N.J.,Jan. 12, 2026/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on Tuesday, January 27, 2026, at 1:00 p.m. (ET).
As described in the proxy materials for the Annual Meeting previously distributed, shareholders as of the close of business on December 8, 2025, or their duly authorized proxies, will be able to attend and participate in the Annual Meeting, vote their shares and ask questions by visitinghttps://meetnow.global/MFT7Y46. Guests may also access the Annual Meeting but in listen-only mode. No control number is required for guests.
A replay of the webcast will be available shortly after the Annual Meeting on the BD website atinvestors.bd.comfor approximately one year from the date of the Annual Meeting.
About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X (formerly Twitter)@BDandCoor Instagram@becton_dickinson.
Contacts:
Media: Investors:
Fallon McLoughlin Adam Reiffe
Director, Public Relations Vice President, Investor Relations
201.258.0361 201.847.6927
fallon.mcloughlin@bd.com adam.reiffe@bd.com

Frequently Asked Questions

When is the BD 2026 Annual Meeting of Shareholders?

The BD 2026 Annual Meeting will be held on January 27, 2026, at 1:00 p.m. ET.

How can shareholders participate in the meeting?

Shareholders can participate by visiting the provided link and voting their shares.

Is there a way for guests to attend the meeting?

Yes, guests can access the meeting in listen-only mode without a control number.

Will a replay of the meeting be available?

Yes, a replay will be available on the BD website for approximately one year.

Last updated: Jan 13, 2026